Transit Officer Paul DeGeorge thought his son was lying on him. Then he realized something much scarier was happening.

This breakthrough, which is a first in the Triad, offers a new option for patients with severe tricuspid regurgitation, a ...

JenaValve announced today that it has received FDA premarket approval (PMA) for its Trilogy transcatheter heart valve system.

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...

No one was more surprised than Dr. Rick Dearman when he was diagnosed with severe symptomatic aortic stenosis, also known as heart valve failure. As a heart surgeon, he’d treated hundreds of people ...

Even women who felt well before pregnancy may begin to notice symptoms around 28 to 30 weeks, when the cardiovascular system reaches its peak workload.

Conditions of the heart often develops silently over time, refusing attention until they begin to impact everyday life. One of such conditions is a Leaky Heart Valve or heart valve regurgitation, ...